Navigation Links
Slumps in Pharmaceutical Profitability Tied to Insufficient Management Training
Date:10/14/2009

SCOTTSDALE, Ariz., Oct. 14 /PRNewswire/ -- When it comes to slumping profitability in the current pharmaceutical sales industry, it is easy to point a finger at a shrinking sales force, the economic downturn and strict government regulations. But new data from the 2009 Leadership Skills Survey, conducted by pharmaceutical consulting firm DELTA POINT, Inc. (http://www.gottochange.com), indicates that the root of the problem actually rests with the productivity of sales associates. More importantly, their productivity directly depends on the robust training of selling and relationship-building skills of new and seasoned managers alike. According to the survey results, without such development, managers cannot properly empower sales associates to meet and exceed their goals.

"Through the 2009 Leadership Skills Survey, we discovered that the success of a pharmaceutical sales rep is determined by this person's ability to foster meaningful customer relationships and create beneficial dialogue with customers -- which then generates results," says Jerry Acuff, DELTA POINT's CEO. "Yet all this stems from the manager's abilities as a skilled leader and trainer. In fact, over 90 percent of our survey respondents said it is the manager's responsibility to improve the sales representative's skills."

Specifically, the 2009 Leadership Skills Survey explored the training needs of sales associates and their managers. Various professionals within the pharmaceutical industry completed the surveys -- from district sales managers to marketing directors to vice presidents. The pool of respondents represented 20 different pharmaceutical companies, including eight of the top 10 pharmaceutical companies nationwide. Officially released this week, the study's key findings include:

  • Over 90 percent of respondents believe it is the manager's responsibility to assist the sales reps in building customer connections.
  • Approximately two-thirds of respondents think their companies don't provide adequate training around sales skills and relationship building for managers.
  • A significant gap exists between the importance placed on skills that enhance customer relationships and the training structure and opportunities that pharmaceutical companies are currently providing managers.

Despite the need for stronger managerial training, as well as greater education among the sales force, only 32 percent of respondents indicated that their companies offer a formalized program for improving sales skills. Meanwhile, a mere 34 percent receive training that is dedicated to the specific concerns related to improving customer relationships, and particularly those of a more challenging nature.

For more information about the 2009 Leadership Skills Survey, email jacuff@gottochange.com.

About DELTA POINT, Inc.

As a consulting company that works mostly with pharmaceutical companies, DELTA POINT focuses on improving outcomes to help brands that are facing challenges whether it is launching a new product, underperforming due to a noisy marketplace and/or facing stiff competition, or having difficulties in communicating the brand message. DELTA POINT works with marketing, sales management, sales training and sales operations as a partner in attaining business success through improving sales messaging and providing its clients with a proven method of building, sustaining and growing substantive business relationships.

    Contact:

    Jerry Acuff
    DELTA POINT, Inc.
    480-296-9972
    E-mail: jacuff@gottochange.com

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.

SOURCE DELTA POINT, Inc.


'/>"/>
SOURCE DELTA POINT, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Catalyst Pharmaceutical Partners, Inc. Announces Organizational Changes and Extension of Chief Executives Employment Agreement
2. VIA Pharmaceuticals Receives Favorable Hearing Decision From NASDAQ
3. The Governator and the Disintegrator: A Sharp Match Holding Pharmaceutical Companies Accountable
4. Vanda Pharmaceuticals Enters into an Exclusive License Agreement for the Commercialization and Development of Fanapt(TM) in the U.S. and Canada for the Treatment of Schizophrenia
5. Vion Pharmaceuticals Engages Merriman Curhan Ford to Evaluate Strategic Alternatives
6. Arena Pharmaceuticals Lorcaserin to be Featured in Multiple Presentations at Obesity 2009
7. Onyx Pharmaceuticals to Acquire Proteolix, Inc.
8. Onyx Pharmaceuticals Announces Investor Teleconference and Webcast
9. ADVENTRX Pharmaceuticals Announces Closing of Financing
10. Savient Pharmaceuticals Prices Underwritten Offering of Common Stock
11. Reportlinker Adds Reinventing Pharmaceutical Sales Forces
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... , April 20, 2017  RXi Pharmaceuticals ... innovative therapeutics that address significant unmet medical needs, ... from the Company,s consumer product development program, based ... the Society for Investigative Dermatology (SID) 76 th ... advance and promote the sciences relevant to skin ...
(Date:4/20/2017)... BOSTON , April 20, 2017   ZappRx, Inc ... the specialty drug prescribing process, today announced it closed $25 ... Fund, a venture capital firm based in Seattle ... Qiming Venture Partners . The Series B round included ... A round in 2014, and GV (formerly Google ...
(Date:4/20/2017)... 20, 2017 Eyevensys, a private ... non-viral gene expression technology that enables the safe, local, ... address a wide range of ophthalmic diseases, announces it ... products Regulatory Agency (MHRA) to advance its technology into ... ...
Breaking Medicine Technology:
(Date:4/28/2017)... , ... April 28, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House ... name the Creator responds to and which He does not. Yisrayl says with so ... one is the true name, but he says with a little Scripture, backed with a ...
(Date:4/28/2017)... ... April 28, 2017 , ... Phytomer USA ... region. Côté has 20+ years of experience within the beauty industry, ranging from ... an array of high-end cosmetic brands, retail brands and outlets in Canada and ...
(Date:4/28/2017)... ... April 28, 2017 , ... Woolsy Corporation ... supplements, through its Nova Skin Sciences division, recently announced the launch of Allumière ... with the power of an anti-aging concentrate. , Anogeissus Leiocarpa Bark ...
(Date:4/28/2017)... ... ... Rob Lowe is a popular actor that has been in many different movies ... as the host of the “Informed” series. The program focuses on many important issues ... focuses on thyroid cancer. , Although thyroid cancer is an uncommon type of cancer, ...
(Date:4/28/2017)... ... April 28, 2017 , ... Christie Medical Holdings, Inc. ... alliance with B. Braun Medical Inc. , a leader in infusion therapy and ... with as many as 90 percent of hospital patients receiving a peripheral IV catheter ...
Breaking Medicine News(10 mins):